0001209191-23-018472.txt : 20230314 0001209191-23-018472.hdr.sgml : 20230314 20230314163010 ACCESSION NUMBER: 0001209191-23-018472 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230312 FILED AS OF DATE: 20230314 DATE AS OF CHANGE: 20230314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Konidaris Tasos CENTRAL INDEX KEY: 0001320982 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 23731456 MAIL ADDRESS: STREET 1: 103 JFK PARKWAY CITY: SHORT HILLS STATE: NJ ZIP: 07078 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-12 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001320982 Konidaris Tasos C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 0 1 0 0 Executive Vice President & CFO Class A Common Stock 2023-03-12 4 M 0 87719 A 380840 D Restricted Stock Units 2023-03-12 4 M 0 87719 0.00 D Class A Common Stock 87719 87720 D Represents shares of the Issuer's Class A Common Stock awarded to the reporting person in connection with the vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 12, 2020, the reporting person was granted 350,877 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. Denis Butkovic, Attorney-in-Fact 2023-03-14